UNH Stock Analysis — UnitedHealth Group
Sector: Healthcare
AI Verdict
UNH trades at 20.9x next year's earnings while analysts expect 53.2% EPS growth — that's cheap for the growth you're getting if its integrated data and care moat holds up.
Competitive Moat
UnitedHealth Group combines a dominant health insurance business (UnitedHealthcare) with Optum, a data-driven healthcare services arm that integrates pharmacy benefits, care delivery, and analytics. The scale of its claims data and vertical integration across insurance and care delivery create switching costs and pricing power that smaller rivals can't match.
Summary
UNH is in focus as analysts expect a massive 53.2% jump in earnings over the next year.
Where It Stands
With a 1-year return of 39.63%, an RSI of 60.5 (neutral), and a forward P/E of 20.9x versus the healthcare sector median of 22x, UNH is delivering above-average growth at a sector-average price.
Key Metrics
- RSI: 60.5 — Near Overbought
- Trailing P/E: 32.1x
- Forward P/E: 20.9x
- PEG Ratio: 0.60
- Earnings Growth: +0.5%
- Market Cap: $385.6B
- 1-Year Return: 39.63%
Analyst Consensus
27 Buy · 6 Hold · 1 Sell (34 analysts) · Target $443.25
Bull Case
A forward P/E of 20.9x for 53.2% expected EPS growth is cheap for the growth on offer, especially given the moat from its integrated data and care model.
Bear Case
If UNH's forward P/E compresses to the sector median of 22x without delivering on the 53.2% EPS growth, the stock could stagnate or fall despite its 39.63% 1-year run.
Catalyst to Watch
Quarterly earnings and Optum segment growth will be critical — any miss on the 53.2% EPS growth expectation could trigger a sharp rerating.